AMTD IDEA GROUP (AMTD)       1.7  +0.03 (+1.8%)

1.7  +0.03 (+1.8%)

US00180G2057 - ADR - Premarket: 1.71 +0.01 (+0.59%)


Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AMTD. AMTD was compared to 205 industry peers in the Capital Markets industry. AMTD has a great financial health rating, but there are some minor concerns on its profitability. AMTD is valued quite cheap, while showing a decent growth score. This is a good combination!

Note: AMTD has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

6

AMTD's Return On Assets of 11.29% is amongst the best returns of the industry. AMTD outperforms 82% of its industry peers. The industry average Return On Assets is 4.11%.
AMTD's Profit Margin of 128.34% is amongst the best returns of the industry. AMTD outperforms 99% of its industry peers. The industry average Profit Margin is 20.52%.

AMTD has a Return On Equity of 12.55%. This is comparable to the industry average of 11.60%.
The Piotroski-F score of AMTD is 5.00. This is a neutral score and indicates average health and profitability for AMTD.
VS Industry

ROA (11.29%) VS Industry: 82% outperformed.

0.03
49.12

ROE (12.55%) VS Industry: 53% outperformed.

0.18
291.37

Profit Margin (128.34%) VS Industry: 99% outperformed.

0.30
84,632.11

Valuation

Valuation Rating

8

The Price/Earnings Ratio is 3.62, which indicates a rather cheap valuation of AMTD.
AMTD's Price/Earning Ratio is rather cheap when compared to the industry average which is at 11.26. AMTD is also cheaper than 94% of the companies in the same industry.
AMTD's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a price book ratio of 0.58, AMTD is valued rather cheaply.
When comparing the price book ratio of AMTD to the average industry price book ratio of 1.21, AMTD is valued rather cheaply. AMTD is also cheaper than 87% of the companies listed in the same industry.
When comparing the Enterprise Value to EBITDA ratio of AMTD to the average industry ratio of 12.50, AMTD is valued rather cheaply.
VS Industry

Price/Earnings (3.62) VS Industry: 94% outperformed.

266.00
0.95

Price/Book (0.58) VS Industry: 87% outperformed.

75.74
0.16

Enterprise Value/ EBITDA (7.1) VS Industry: 68% outperformed.

167.26
0.67

Growth

Growth Rating

4

The Earnings Per Share has grown by an nice 11.59% over the past year.
AMTD shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 24.99% yearly.

Looking at the last year, AMTD shows a small growth in Revenue. The Revenue has grown by 9.77% in the last year.
AMTD shows a very negative growth in Revenue. Measured over the last 5 years, the Revenue has been decreasing by -23.81% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS24.99% 22.93% 11.59% N/A N/A N/A N/A
Revenue-23.81% -46.09% 9.77% N/A N/A N/A N/A

Health

Health Rating

9

AMTD has a Current Ratio of 9.06. This indicates that AMTD is financially healthy and has no problem in meeting its short term obligations.
AMTD is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.42. AMTD has a better rating than 88% of its industry peers.
AMTD has a Quick Ratio of 9.06. This indicates that AMTD is financially healthy and has no problem in meeting its short term obligations.
AMTD is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.42. AMTD has a better rating than 88% of its industry peers.

When comparing the Debt to Equity Ratio of 0.00 to an average industry Debt to Equity of 0.62, AMTD is way less dependent on financing that its industry peers.
An Altman-Z score of 5.93 indicates that AMTD is not in any danger for bankruptcy at the moment.
The Altman-Z score of AMTD is much better than the industry average of 1.06. AMTD has a better rating than 88% of its industry peers.
The Piotroski-F score of AMTD is 5.00. This is a neutral score and indicates average health and profitability for AMTD.
VS Industry

Debt/Equity (0) VS Industry: 78% outperformed.

8.26
0.00

Quick Ratio (9.06) VS Industry: 88% outperformed.

0.01
5,803.88

Current Ratio (9.06) VS Industry: 88% outperformed.

0.01
5,803.88

Altman-Z (5.93) VS Industry: 88% outperformed.

-98.91
5,478.90

Dividend

Dividend Rating

0

AMTD does not give a dividend.

AMTD IDEA GROUP1.7

NYSE:AMTD (2/1/2023, 7:04:00 PM)+0.03 (+1.8%)

Premarket: 1.71 +0.01 (+0.59%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Diversified Financials
GICS Industry Capital Markets
Earnings (Last) N/A N/A Earnings (Next) 12-13 2022-12-13/amc
Inst Owners 59.63% Inst Owner Change 0%
Ins Owners N/A Ins Owner Change 0%
Market Cap 641.93M Analysts 82.86
Price Target 9.18 (440%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP 0% Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) 0% PT rev (3m) 0%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) N/A EPS NY rev (3m) N/A
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) N/A Revenue NY rev (3m) N/A

Valuation
Industry RankSector Rank
PE 3.62
Fwd PE N/A
P/S 5.89
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.63
EV/EBITDA 7.1
EPS(TTM) 0.47 EY 27.65%
EPS(NY) N/A Fwd EY N/A
FCF(TTM) N/A FCFY N/A
OCF(TTM) N/A OCFY N/A
SpS 0.29 BVpS 2.95
TBVpS 2.68 PEG (NY) N/A
PEG (5Y) 0.14

Profitability
Industry RankSector Rank
ROA 11.29%
ROE 12.55%
ROIC 6.83%
ROICexc 7.02%
ROICexgc 7.71%
OM 79.12%
PM 128.34%
GM 99.85%
ROICexgc(3y) 73.78% ROICexcg growth 3Y N/A
ROICexcg growth 5Y -28.35% ROICexc(3y) 18.53%
ROICexc growth 3Y -31.63% ROICexc growth 5Y -13.61%
OM growth 3Y 29.24% OM growth 5Y 14.84%
PM growth 3Y 68.1% PM growth 5Y 38.36%
GM growth 3Y 1.13% GM growth 5Y 0.81%
F-Score 5 Asset Turnover 0.09

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr N/A
Profit Quality N/A
Current Ratio 9.06
Quick Ratio 9.06
Altman-Z 5.93
F-Score 5 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) 145.83%
Cap/Depr(5y) 125.45% Profit Quality(3y) 187.95%
Profit Quality(5y) N/A

Growth
EPS 1Y 11.59% EPS 3Y 22.93%
EPS 5Y 24.99% EPS growth Q2Q 10.52%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y 9.77% Revenue growth 3Y -46.09%
Revenue growth 5Y -23.81% Revenue growth Q2Q 13.35%
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y 15.86% EBIT growth 3Y -30.32%
EBIT growth 5Y -12.5% EBIT Next Year N/A
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y -78.2% FCF growth 3Y N/A
FCF growth 5Y -20.43% OCF growth 1Y -78.2%
OCF growth 3Y N/A OCF growth 5Y -21.6%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA